|
NEW
PEDIATRIC ASTHMA GUIDELINES
RELEASED
WASHINGTON,
DC-Representatives
from nine prominent health care organizations recently joined forces to
create a new set of pediatric asthma guidelines, Pediatric Asthma:
Promoting Best Practice.(1) "These are the first asthma guidelines
devoted entirely to the pediatric patient," noted Laurie Smith, MD,
chair of the Section on Allergy/Immunology at the American Academy of
Pediatrics, one of the organizations involved in developing the guidelines.
Separate pediatric asthma
guidelines are necessary because pediatric asthma rates are on the rise-they
jumped 72% among children age 5 to 16 years from 1980 to 1994.(2) Furthermore,
having specific pediatric recommendations prevents information on childhood
asthma from being buried among adult data, said Gail G. Shapiro, MD, co-chair
of the committee that created the guidelines.
KEYS TO SUCCESSFUL ASTHMA MANAGEMENT
The new guidelines remind
physicians that asthma diagnosis consists of three basic steps:
- Suspect asthma if initial
symptoms suggest it.
- Establish the diagnosis
with a careful history, focusing on the patient's symptom patterns.
- Confirm the diagnosis with
objective measures, particularly spirometry, which is the gold standard in
asthma diagnosis.
Assessment frequency depends
on disease severity and ranges from only two office visits a year for children
whose asthma is under control to an office visit every 2 weeks for those with
unstable asthma. To gauge severity, physicians need to consider a variety of
factors, such as symptoms and school absences during any 2-week period, fatigue,
poor school performance, and (in asthmatic infants) chest retractions and difficulty
in feeding.
Spirometry is recommended
at least once a year for all patients. It is also necessary at the initial visit,
after the start of treatment (when symptoms and peak flow have stabilized),
and to evaluate treatment changes. Long-term home peak flow monitoring is especially
important for asthmatic children with poor symptom perception, moderate to severe
disease, and/or a history of severe exacerbations.
Environmental triggers, such
as viral upper respiratory infection, influenza, dust mites, and tobacco smoke,
can worsen childhood asthma. The guidelines suggest many ways to minimize these
triggers, such as annual influenza vaccination for children with persistent
asthma who are not allergic to eggs (a component of the vaccine) and helping
parents and other caregivers to stop smoking.
TWO USES FOR DRUG THERAPY
The goal of management,
according to the guidelines, is to control asthma with as little medication
as possible; in that way, adverse effects can be minimized. Long-term
asthma control and quick relief of acute symptoms are the two uses of
pharmacologic therapy for pediatric asthma. For long-term control, the
guidelines recommend cromolyn sodium, inhaled and oral corticosteroids,
leukotriene modifiers, long-acting ß2-agonists, nedocromil
sodium, and sustained-release theophylline. Short-acting inhaled or oral
ß2-agonists, short-course oral corticosteroids, and ipratropium
bromide are recommended for quick relief.
Physicians should adopt a
stepwise approach to these therapies, basing the amount and frequency of medication
on disease severity. The following are the overall goals of pharmacologic therapy:
- Minimal or no symptoms
during the day or night.
- Minimal or no asthma
episodes.
- Minimal (less than
once a day) short-acting ß2-agonist use.
- A peak expiratory
flow at least 80% of personal best.
- Minimal or no adverse
effects.
- Normal activities.
Whether inhaled corticosteroids
inhibit growth in children is controversial. According to the guidelines, the
benefits of these medications offset this potential risk. Nevertheless, physicians
should regularly monitor growth in pediatric asthma patients receiving inhaled
corticosteroids.
EDUCATING PATIENTS AND THEIR CAREGIVERS
Although time-consuming, providing
patients and their caregivers sufficient information about asthma on an ongoing
basis will improve adherence to therapy. "Education works best when it's
a partnership with the patient and family," said Dr. Smith. It's vital,
she added, to share the information with grandparents, teachers, coaches, and
others outside the immediate family who are involved with the patient's care.
Two crucial components of
asthma education are a management plan and an action plan. The management plan
can be a simple one-page sheet outlining daily interventions for long-term control.
The action plan provides brief written instructions on handling asthma exacerbations.
Because children spend so
much time at school, physicians should work with school personnel to ensure
a safe, positive environment for asthmatic students. Asthma triggers in the
school environment should be minimized as much as possible. Physicians and school
personnel should work together to develop an asthma management plan and should
provide help so that asthmatic students can adhere to it. School personnel should
be educated about specific asthma monitoring and treatment techniques, including
the action plan.
School personnel should also
strive to provide a normal environment in which asthmatic students aren't singled
out because of their disorder. "They should understand that just because
a child has asthma doesn't mean he or she should necessarily be excused from
[physical education] or put in a bubble," Dr. Shapiro emphasized. "It's
important that children with asthma live a normal lifestyle. Almost everyone
with asthma can do that."
-Timothy
M. Begany
References
1. Rachelefsky GS, Shapiro GG, Bergman D, et al. Pediatric Asthma: Promoting
Best Practice. 1999. Milwaukee, Wis: American Academy of Allergy, Asthma &
Immunology Inc; 1999.
2. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma-United
States, 1960-1995. Mor Mortal Wkly Rep CDC Surveill Summ. 1998;47:1-27.
|